BackShanghai Fudan-Zhangjiang Bio-Pharmaceutical ,Ltd. Overview
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical ,Ltd. Return on Equity

Latest ROE for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical ,Ltd.: -4.79% — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

ROE

-4.79%

Return on Equity

-4.79%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical ,Ltd. (1349.HK) FAQ

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical ,Ltd. (1349.HK) currently reports a ROE of -4.79%. That is below the sector sector average of 11.3%. Use the charts on this page to explore Shanghai Fudan-Zhangjiang Bio-Pharmaceutical ,Ltd.'s ROE history and peer comparisons.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical ,Ltd.'s ROE of -4.79% is lower than the its sector sector average of 11.3%. That is roughly 142.4% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Shanghai Fudan-Zhangjiang Bio-Pharmaceutical ,Ltd.'s current -4.79% should be judged against industry norms (sector average: 11.3%) and against 1349.HK's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of -4.79%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 11.3%. From there, open related valuation or income-statement pages for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical ,Ltd., and consider following 1349.HK for alerts when major investors trade the stock.